Filing Details

Accession Number:
0001209191-21-037024
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-06-01 21:51:15
Reporting Period:
2021-06-01
Accepted Time:
2021-06-01 21:51:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1845337 Day One Biopharmaceuticals Inc. DAWN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1776351 A. John Josey 395 Oyster Point Blvd, Suite 217
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-06-01 7,000 $16.00 72,292 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy Common Stock) Acquisiton 2021-05-26 63,000 $0.00 63,000 $16.00
Common Stock Stock Option (right to buy Common Stock) Acquisiton 2021-05-26 1,181 $0.00 1,181 $16.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
63,000 2031-05-25 No 4 A Direct
1,181 2031-05-25 No 4 A Direct
Footnotes
  1. Certain of the shares are subject to the Issuer's right of repurchase if underlying vesting conditions are not met.
  2. The option vests as to 1/36th of the total shares on each monthly anniversary, beginning on June 26, 2021, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
  3. The Reporting Person is reporting the acquisition of these securities pursuant to Rule 16a-2(a) of the Exchange Act.
  4. The option vests as to 1/48th of the total shares on each monthly anniversary, beginning on November 6, 2020, subject to the Reporting Person's provision of service to the Issuer on each vesting date.